MAP4K4 and hepatocellular carcinoma: Moreover, growing evidence shows MAP4K4 upregulation, e.g., in pancreatic ductal adenocarcinoma [27], hepatocellular carcinoma [28] or lung adenocarcinoma [29], but the role of MAP4K4 in skin cancer development is to be elucidated.